February 11, 2015
Rakesh Jhunjhunwala bought 34,85,075 shares of Fortis Healthcare through bulk deal on the BSE today. The scrips were purchased on an average price of Rs 119.35 per share at a total transaction value at Rs 41.6 crore
Shares of Fortis Healthcare climbed by 20 per cent to settle at 52-week high of Rs 138.90 a piece.
Fortis Healthcare Ltd., incorporated in the year 1996, is a Mid Cap company (having a market cap of Rs 6430.45 Cr.) operating in Pharmaceuticals and health care sector.
Fortis Healthcare Ltd. key Products/Revenue Segments include HealthCare Services which contributed Rs 346.48 Cr to Sales Value (93.28% of Total Sales), Other Operating Revenue which contributed Rs 13.42 Cr to Sales Value (3.61% of Total Sales), Pharmaceuticals which contributed Rs 10.09 Cr to Sales Value (2.71% of Total Sales), Lease Rentals which contributed Rs 1.17 Cr to Sales Value (0.31% of Total Sales), Export Incentives which contributed Rs 0.24 Cr to Sales Value (0.06% of Total Sales), for the year ending 31-Mar-2014.
For the quarter ended 30-Sep-2014, the company has reported a Standalone sales of Rs. 152.76 Cr., up 3.33% from last quarter Sales of Rs. 147.84 Cr. and up 78.88% from last year same quarter Sales of Rs. 85.40 Cr. Company has reported net profit after tax of Rs. -5.09 Cr. in latest quarter.
The company’s management includes Mr.Rahul Ranjan, Dr.Brian Tempest, Dr.Preetinder Singh Joshi, Mr.Gurcharan Das, Mr.Harpal Singh, Mr.Malvinder Mohan Singh, Mr.Pradeep Ratilal Raniga, Mr.Shivinder Mohan Singh, Mr.Sunil Godhwani, Mr.Udai Dhawan, Ms.Joji Sekhon Gill, Ms.Lynette Joy Hepburn Brown, Mr.Gagandeep Singh Bedi, Mr.Rahul Ranjan, Mr.Sandeep Puri.
Company has S R Batliboi & Co. as its auditors. As on 31-Dec-2014, the company has a total of 462,788,914 shares outstanding.